Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Medicine, Pemetrexed, Apatinib, Angiogenesis, Bevacizumab, and Dexamethasone.
Efficacy and Safety of Intrathecal Pemetrexed Combined With Dexamethasone for Treating Tyrosine Kinase Inhibitor-Failed Leptomeningeal Metastases From EGFR-Mutant NSCLC—a Prospective, Open-Label, Single-Arm Phase 1/2 Clinical Trial (Unique Identifier: ChiCTR1800016615)
Comparison of efficacy and toxicity of bevacizumab, endostar and apatinib in transgenic and human lung cancer xenograftzebrafish model
Evaluation of the efficacy of anti-angiogenic agents, alone and in combination with pemetrexed in the zebrafish model.